Table 1.
Patient demographics, clinical characteristics, echo findings at the time of surgery. Normal data are presented ± SD. Non-normal data are presented [inter-quartile range]. Data are also present stratified by whether or not CABG was performed at the time of mitral valve surgery.
| Overall (n=108) | CABG (n=43) | No CABG (n=65) | p-value | |
|---|---|---|---|---|
| Age (years) | 64±13 | 67±11 | 62±13 | 0.05 |
| Male (%) | 38 | 42 | 35 | 0.48 |
| Mitral replacement (%) | 61 | 51 | 68 | 0.08 |
| Mitral leaflet disease (%) | 40 | 16 | 35 | 0.03 |
| Median LVEF (%) | 46 [36,60] | 42 [35,60] | 50 [36,60] | 0.37 |
| Mean LVEF (%) | 47±14 | 45±13 | 48±15 | 0.38 |
| LA diameter (mm) | 50±8 | 48±8 | 51±8 | 0.09 |
| LV diastolic diameter | 58±9 | 56±6 | 59±10 | 0.11 |
| LV systolic diameter | 45±12 | 45±10 | 45±13 | 0.96 |
| Renal Insufficiency (%) | 27 | 23 | 29 | 0.49 |
| Hematocrit (%) | 36 [32,41] | 36 [32,39] | 36 [32,40] | 0.90 |
| Body Mass Index | 26±5 | 26±4 | 27±5 | 0.74 |
| Race | ||||
| White (%) | 26 | 35 | 20 | 0.08 |
| Black (%) | 30 | 19 | 37 | 0.04 |
| Hispanic (%) | 10 | 7 | 12 | 0.37 |
| Other/unkown (%) | 34 | 40 | 31 | 0.35 |